Related Experiment Videos
IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease
M Huberman1, B Sredni, L Stern
1C.A.I.R. Institute, Marilyn Finkler Cancer Research Center, Bar Ilan University, Ramat Gan, Israel.
Abstract:
The production of interleukin-2 (IL-2) and interleukin-6 (IL-6) by peripheral blood mononuclear cells (MNC) was assessed in patients with Alzheimer's disease (AD) who were subdivided into two groups--mild and moderately-severe--according to the severity of the disease, probable vascular dementia (VaD) patients and elderly control subjects. No differences in IL-2 secretion were found between mild AD patients and controls. However, there was a significant increase in IL-2 production both in the moderately-severe AD group and in the VaD group. IL-6 levels in AD patients of both groups were similar and significantly higher than those of VaD and controls. Our results suggest that increased levels of IL-2-production correlate with severity of the dementia, whereas increased levels of IL-6 production seem to be related to AD and thus may play a role in AD pathogenesis.
Insights
Interleukin-6 (IL-6) levels are elevated in Alzheimer's disease (AD) patients, suggesting a role in AD pathogenesis. Interleukin-2 (IL-2) production increases with dementia severity in AD and vascular dementia (VaD).
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- The role of inflammatory cytokines, such as interleukin-2 (IL-2) and interleukin-6 (IL-6), in AD pathogenesis is under investigation.
- Peripheral blood mononuclear cells (MNC) are immune cells that can be analyzed for cytokine production.
Purpose of the Study:
- To investigate the production of IL-2 and IL-6 by MNC in patients with mild and moderately-severe AD, probable vascular dementia (VaD), and elderly controls.
- To determine the correlation between cytokine levels and dementia severity.
Main Methods:
- Peripheral blood mononuclear cells (MNC) were isolated from patients with Alzheimer's disease (AD) (mild and moderately-severe), probable vascular dementia (VaD), and elderly controls.
- The production of IL-2 and IL-6 by MNC was measured.
Main Results:
- IL-2 production was significantly increased in moderately-severe AD patients and VaD patients compared to controls.
- IL-6 levels were significantly higher in both mild and moderately-severe AD patients compared to VaD patients and controls.
- IL-2 production correlated with dementia severity.
Conclusions:
- Increased IL-2 production is associated with the severity of dementia in AD and VaD.
- Elevated IL-6 levels are linked to AD, suggesting a potential role in its pathogenesis.
- Cytokine profiling of MNC may offer insights into dementia subtypes and disease progression.